Delaware
|
11-2481903
|
(State
or other jurisdiction of incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
1450
Broadway, New York, NY
|
10018
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Large accelerated filer x | Accelerated filer o | |||
Non-accelerated filer
o
(Do not check if a smaller reporting
company)
|
Smaller reporting company o |
|
|
|
|
Page
No.
|
Part
I.
|
|
Financial
Information
|
|
3
|
|
|
|
|
|
Item
1.
|
|
Financial
Statements
|
|
|
|
|
Condensed
Consolidated Balance Sheets - March 31, 2008 (unaudited) and December
31,
2007
|
|
3
|
|
|
Unaudited
Condensed Consolidated Income Statements - Three Months Ended March
31,
2008 and 2007
|
|
4
|
|
|
Unaudited
Condensed Consolidated Statement of Stockholders' Equity - Three
Months
Ended March 31, 2008
|
|
5
|
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows - Three Months Ended
March
31, 2008 and 2007
|
|
6
|
|
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
|
7
|
|
|
|
|
|
Item
2.
|
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
|
18
|
|
|
|
|
|
Item
3.
|
|
Quantitative
and Qualitative Disclosures about Market Risk
|
|
21
|
|
|
|
|
|
Item
4.
|
|
Controls
and Procedures
|
|
22
|
|
|
|
|
|
Part
II.
|
|
Other
Information
|
|
22
|
|
|
|
|
|
Item
1.
|
|
Legal
Proceedings
|
|
22
|
Item
1A.
|
|
Risk
Factors
|
|
22
|
Item
2.
|
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
|
25
|
Item
5
|
|
Other
Information
|
|
25
|
Item
6.
|
|
Exhibits
|
|
25
|
|
|
|
|
|
Signatures
|
|
|
|
26
|
March
31,
2008
|
December
31,
2007
|
||||||
(Unaudited)
|
|||||||
Assets
|
|||||||
Current
Assets:
|
|||||||
Cash
(including restricted cash of $3,839 in 2008 and $5,205 in
2007)
|
$
|
56,336
|
$
|
53,272
|
|||
Accounts
receivable, net of reserve of $3,519 in 2008 and 2007
|
36,636
|
29,757
|
|||||
Deferred
income tax assets
|
7,442
|
7,442
|
|||||
Prepaid
advertising and other
|
6,114
|
5,397
|
|||||
Total
Current Assets
|
106,528
|
95,868
|
|||||
Property
and equipment:
|
|||||||
Furniture,
fixtures and equipment
|
3,341
|
2,903
|
|||||
Less:
Accumulated depreciation
|
(1,681
|
)
|
(1,610
|
)
|
|||
|
1,660
|
1,293
|
|||||
Other
Assets:
|
|||||||
Restricted
cash
|
15,865
|
15,186
|
|||||
Marketable
securities
|
10,660
|
10,920
|
|||||
Goodwill
|
128,898
|
128,898
|
|||||
Trademarks
and other intangibles, net
|
1,036,390
|
1,038,201
|
|||||
Deferred
financing costs, net
|
7,836
|
8,270
|
|||||
Non-current
deferred income tax assets
|
12,867
|
21,158
|
|||||
Other
|
15,930
|
16,336
|
|||||
|
1,228,446
|
1,238,969
|
|||||
Total
Assets
|
$
|
1,336,634
|
$
|
1,336,130
|
|||
|
|||||||
Liabilities
and Stockholders' Equity
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
18,016
|
$
|
15,804
|
|||
Accounts
payable, subject to litigation
|
1,878
|
1,878
|
|||||
Deferred
revenue
|
1,885
|
6,162
|
|||||
Current portion of long-term debt
|
33,035
|
52,566
|
|||||
Total
current liabilities
|
54,814
|
76,410
|
|||||
|
|||||||
Deferred
income taxes
|
70,836
|
73,418
|
|||||
Long-term
debt, less current maturities
|
648,898
|
649,590
|
|||||
Long
term deferred revenue
|
8,912
|
8,792
|
|||||
Total
Liabilities
|
783,460
|
808,210
|
|||||
|
|||||||
Commitments
and contingencies
|
|||||||
|
|||||||
Stockholders'
Equity
|
|||||||
Common
stock, $.001 par value
-
shares authorized 150,000; shares issued 57,671 and 57,330
respectively
|
58
|
58
|
|||||
Additional
paid-in capital
|
477,254
|
469,941
|
|||||
Retained
earnings
|
79,185
|
60,941
|
|||||
Accumulated
other comprehensive loss
|
(2,656
|
)
|
(2,353
|
)
|
|||
Less:
Treasury stock - 212 shares at cost
|
(667
|
)
|
(667
|
)
|
|||
Total
Stockholders’ Equity
|
553,174
|
527,920
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
1,336,634
|
$
|
1,336,130
|
Three
Months Ended
March
31,
|
|||||||
2008
|
2007
|
||||||
Licensing
revenue
|
$
|
55,667
|
$
|
30,841
|
|||
|
|||||||
Selling,
general and administrative expenses
|
18,711
|
7,719
|
|||||
Special
charges
|
191
|
763
|
|||||
|
|||||||
Operating
income
|
36,765
|
22,359
|
|||||
|
|||||||
Other
expenses:
|
|||||||
Interest
expense
|
10,121
|
3,535
|
|||||
Interest
income
|
(1,565
|
)
|
(913
|
)
|
|||
Interest
expense- net
|
8,556
|
2,622
|
|||||
|
|||||||
Income
before income taxes
|
28,209
|
19,737
|
|||||
|
|||||||
Provision
for income taxes
|
9,965
|
6,990
|
|||||
|
|||||||
Net
income
|
$
|
18,244
|
$
|
12,747
|
|||
|
|||||||
Earnings
per share:
|
|||||||
Basic
|
$
|
0.32
|
$
|
0.23
|
|||
|
|||||||
Diluted
|
$
|
0.30
|
$
|
0.21
|
|||
|
|||||||
Weighted
average number of common shares outstanding:
|
|||||||
Basic
|
57,422
|
56,402
|
|||||
|
|||||||
Diluted
|
61,350
|
61,243
|
Common
Stock
|
||||||||||||||||||||||
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Treasury
Stock
|
Total
|
||||||||||||||||
Balance
at January 1, 2008
|
57,330
|
$
|
58
|
$
|
469,941
|
$
|
60,941
|
$
|
(2,353
|
)
|
$
|
(667
|
)
|
$
|
527,920
|
|||||||
Exercise
of stock options
|
341
|
-
|
1,206
|
-
|
-
|
-
|
1,206
|
|||||||||||||||
Tax
benefit of stock option exercises
|
-
|
-
|
4,001
|
-
|
-
|
-
|
4,001
|
|||||||||||||||
Amortization
expense in connection with restricted stock
|
-
|
-
|
2,106
|
-
|
-
|
-
|
2,106
|
|||||||||||||||
Comprehensive
income:
|
||||||||||||||||||||||
Net
Income
|
-
|
-
|
-
|
18,244
|
-
|
-
|
18,244
|
|||||||||||||||
Change
in fair value of cash flow hedge
|
-
|
-
|
-
|
-
|
(43
|
)
|
-
|
(43
|
)
|
|||||||||||||
Change
in fair value of securities
|
-
|
-
|
-
|
-
|
(260
|
)
|
-
|
(260
|
)
|
|||||||||||||
Total
comprehensive income
|
-
|
-
|
-
|
-
|
-
|
-
|
17,941
|
|||||||||||||||
Balance
at March 31, 2008
|
57,671
|
$
|
58
|
$
|
477,254
|
$
|
79,185
|
$
|
(2,656
|
)
|
$
|
(667
|
)
|
$
|
553,174
|
Three
Months Ended March 31,
|
|||||||
2008
|
2007
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
income
|
|
$
|
18,244
|
|
$
|
12,747
|
|
Depreciation
of property and equipment
|
|
|
71
|
|
|
39
|
|
Amortization
of trademarks and other intangibles
|
|
|
1,917
|
|
|
903
|
|
Amortization
of deferred financing costs
|
|
|
440
|
|
|
165
|
|
Amortization
of convertible note discount
|
|
|
323
|
|
|
-
|
|
Stock-based
compensation expense
|
|
|
2,106
|
|
|
359
|
|
Bad
debt expense
|
|
|
173
|
|
|
469
|
|
Accrued
interest on long-term debt
|
|
|
1,344
|
|
|
60
|
|
Deferred
income tax provision (benefit)
|
|
|
5,709
|
|
|
6,990
|
|
Changes
in operating assets and liabilities, net of business
acquisitions:
|
|
|
|
|
|
||
Accounts
receivable
|
|
|
(7,052
|
)
|
|
(10,208
|
)
|
Prepaid
advertising and other
|
|
|
(1,217
|
)
|
|
(776
|
)
|
Other
assets
|
|
|
363
|
|
570
|
||
Deferred
revenue
|
|
|
(4,157
|
)
|
|
3,808
|
|
Accounts
payable and accrued expenses
|
|
|
862
|
|
|
(11
|
)
|
Net
cash provided by operating activities
|
|
|
19,126
|
|
|
15,115
|
|
Cash
flows used in investing activities:
|
|
|
|
|
|
||
Purchases
of property and equipment
|
|
|
(438
|
)
|
|
(40
|
)
|
Addition
to trademarks
|
|
|
(106
|
)
|
|
-
|
|
Collection
on promissory note
|
500
|
-
|
|||||
Acquisition
of Danskin
|
|
|
-
|
|
(70,799
|
)
|
|
Acquisition
of Rocawear
|
|
|
-
|
|
(204,233
|
)
|
|
Net
cash used in investing activities
|
|
|
(44
|
)
|
|
(275,072
|
)
|
Cash
flows provided by financing activities:
|
|
|
|
|
|
||
Proceeds
from long-term debt
|
|
|
-
|
|
|
212,500
|
|
Proceeds
from exercise of stock options and warrants
|
|
|
1,206
|
|
|
643
|
|
Payment
of long-term debt
|
|
|
(20,546
|
)
|
|
(4,151
|
)
|
Payment
of expenses related to common stock issuance
|
|
|
-
|
|
(184
|
)
|
|
Deferred
financing costs
|
|
|
-
|
|
(3,915
|
)
|
|
Excess
tax benefit from share-based payment arrangements
|
|
|
4,001
|
|
|
-
|
|
Restricted
cash - current
|
|
|
1,366
|
|
2,338
|
|
|
Restricted
cash - non-current
|
|
|
(679
|
)
|
|
(1,085
|
)
|
Net
cash provided by (used in) financing activities
|
|
|
(14,652
|
)
|
|
206,146
|
|
Net
increase (decrease) in cash and cash equivalents
|
|
|
4,430
|
|
(53,811
|
)
|
|
Cash
and cash equivalents, beginning of period
|
|
|
48,067
|
|
|
73,572
|
|
Cash
and cash equivalents, end of period
|
|
$
|
52,497
|
|
$
|
19,761
|
|
Balance
of restricted cash - current
|
|
|
3,839
|
|
|
1,930
|
|
Total
cash and cash equivalents including current restricted cash, end
of
period
|
$
|
56,336
|
$
|
21,691
|
Three
Months Ended March 31,
|
|||||||
2008
|
2007
|
||||||
Cash
paid during the period:
|
|||||||
Income
taxes
|
$
|
343
|
$
|
291
|
|||
Interest
|
$
|
7,823
|
$
|
3,375
|
Three
Months Ended March 31,
|
|||||||
2008
|
2007
|
||||||
Acquisitions:
|
|||||||
Common
stock issued
|
$
|
-
|
$
|
496
|
|||
Warrants
issued - acquisition cost
|
$
|
-
|
$
|
4,931
|
Carrying
Amount as of March 31, 2008
|
Level
1
|
Level
2
|
Level
3
|
Valuation
Technique |
||||
Marketable
Securities
|
ü
|
ü
|
(B)
and (C)
|
|||||
Cash
Flow Hedge
|
ü
|
(A)
|
Description
|
Auction
Rate Securities
|
|||
Balance
at January 1, 2008
|
$
|
10,920
|
||
Additions
|
- | |||
Gains
(losses) reported in earnings
|
- | |||
Gains
(losses) reported in other comprehensive income
|
(260
|
)
|
||
Balance
at March 31, 2008
|
$
|
10,660 |
|
March
31, 2008
|
December
31, 2007
|
||||||||||||||
(000's
omitted)
|
Estimated
Lives
in
Years
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
|||||||||||
|
||||||||||||||||
Trademarks:
|
||||||||||||||||
Indefinite
life trademarks
|
indefinite
|
$
|
1,007,731
|
$
|
9,498
|
$
|
1,007,625
|
$
|
9,498
|
|||||||
Definite
life trademarks
|
10-15
|
18,897
|
1,205
|
18,897
|
856
|
|||||||||||
Non-compete
agreements:
|
2-15
|
10,075
|
4,963
|
10,075
|
4,585
|
|||||||||||
Licensing
agreements:
|
1.5-6
|
21,093
|
6,059
|
21,093
|
4,897
|
|||||||||||
Domain
names
|
5
|
570
|
251
|
570
|
223
|
|||||||||||
|
$
|
1,058,366
|
$
|
21,976
|
$
|
1,058,260
|
$
|
20,059
|
March
31,
|
December
31,
|
||||||
(000’s
omitted)
|
2008
|
2007
|
|||||
Convertible
Notes
|
$
|
282,038
|
$
|
281,714
|
|||
Term
Loan Facility
|
255,144
|
270,751
|
|||||
Asset-Backed
Notes
|
132,565
|
137,505
|
|||||
Sweet
Note (Note 7)
|
12,186
|
12,186
|
|||||
Total
Debt
|
$
|
681,933
|
$
|
702,156
|
(000’s
omitted)
|
Total
|
2008
|
2009
|
2010
|
2011
|
2012
|
thereafter
|
|||||||||||||||
Convertible
Notes
|
$
|
282,038
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
282,038
|
$
|
-
|
||||||||
Term
Loan Facility
|
255,144
|
-
|
-
|
-
|
-
|
-
|
255,144
|
|||||||||||||||
Asset-Backed
Notes
|
132,565
|
20,849
|
22,711
|
24,740
|
26,950
|
37,315
|
-
|
|||||||||||||||
Sweet
Note (Note 7)
|
12,186
|
12,186
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||
Total
Debt
|
$
|
681,933
|
$
|
33,035
|
$
|
22,711
|
$
|
24,740
|
$
|
26,950
|
$
|
319,353
|
$
|
255,144
|
Expected
Volatility
|
.30
- .50
|
|||
Expected
Dividend Yield
|
0
|
%
|
||
Expected
Life (Term)
|
3
- 7 years
|
|||
Risk-Free
Interest Rate
|
3.00
- 4.75
|
%
|
Options
|
Weighted-Average
Exercise
Price
|
||||||
Outstanding
January 1, 2008
|
5,106,543
|
$
|
4.23
|
||||
Granted
|
-
|
-
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
340,749
|
4.40
|
|||||
Expired
|
-
|
-
|
|||||
Outstanding
March 31, 2008
|
4,765,794
|
4.22
|
|||||
Exercisable
at March 31, 2008
|
4,681,126
|
4.17
|
Warrants
|
Weighted-Average
Exercise
Price
|
||||||
Outstanding
January 1, 2008
|
266,900
|
$
|
16.76
|
||||
Granted
|
-
|
-
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
-
|
-
|
|||||
Expired
|
-
|
-
|
|||||
Outstanding
March 31, 2008
|
266,900
|
$
|
16.76
|
||||
Exercisable
at March 31, 2008
|
266,900
|
$
|
16.76
|
Securities
|
Weighted
Average
Grant
Date
Fair
Value
|
||||||
Non-vested,
January 1, 2008
|
144,127
|
$
|
19.41
|
||||
Granted
|
1,789,430
|
18.42
|
|||||
Vested
|
(82,835
|
)
|
18.80
|
||||
Forfeited
|
-
|
-
|
|||||
Non-vested,
March 31, 2008
|
1,850,722
|
$
|
18.48
|
(000's
omitted)
|
For
the Three
Months
Ended
March
31,
|
||||||
|
|||||||
2008
|
2007
|
||||||
Basic
|
57,422
|
56,402
|
|||||
Effect
of exercise of stock options
|
3,757
|
4,832
|
|||||
Effect
of contingent common stock issuance
|
144
|
-
|
|||||
Effect
of assumed vesting of restricted stock
|
27
|
9
|
|||||
|
61,350
|
61,243
|
10. Related
Party Transactions
|
·
|
could
impair our liquidity;
|
·
|
could
make it more difficult for us to satisfy our other
obligations;
|
·
|
require
us to dedicate a substantial portion of our cash flow to payments
on our
debt obligations, which reduces the availability of our cash flow
to fund
working capital, capital expenditures and other corporate
requirements;
|
·
|
could
impede us from obtaining additional financing in the future for working
capital, capital expenditures, acquisitions and general corporate
purposes;
|
·
|
impose
restrictions on us with respect to future
acquisitions;
|
·
|
make
us more vulnerable in the event of a downturn in our business prospects
and could limit our flexibility to plan for, or react to, changes
in our
licensing markets; and
|
·
|
place
us at a competitive disadvantage when compared to our competitors
who have
less debt.
|
Month
of purchase
|
Total
number
of
shares
purchased
(1)
|
Average
price
paid
per share
|
Total
number of
shares
purchased
as
part
of publicly announced plans or programs
|
Maximum
dollar
value
of shares
that
may yet be
purchased
under
the plans or
programs
|
|||||||||
January
1 - January 31, 2008
|
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
|||||
February
1 - February 29, 2008
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
March 1
- March 31, 2008
|
13,871
|
$
|
19.00
|
$
|
—
|
$
|
—
|
||||||
Total
|
13,871
|
$
|
19.00
|
$
|
—
|
$
|
—
|
(1)
|
|
Represents
shares of common stock surrendered to the Company to pay employee
withholding taxes due upon the vesting of restricted
stock.
|
EXHIBIT
NO.
|
DESCRIPTION
OF EXHIBIT
|
Exhibit
10.1
|
Employment
Agreement between Neil Cole and the Company dated January 28, 2008
(1)*
|
Exhibit
10.2
|
Restricted
Stock Grant Agreement dated February 19, 2008 between the Company
and Neil
Cole (2)*
|
|
|
Exhibit
10.3
|
Restricted
Stock Performance Unit Agreement dated February 19, 2008 between
the
Company and Neil Cole (2)*
|
|
|
Exhibit
31.1
|
Certification
of Chief Executive Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302
Of The
Sarbanes-Oxley Act of 2002
|
Exhibit
31.2
|
Certification
of Chief Financial Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302
Of The
Sarbanes-Oxley Act of 2002
|
Exhibit
32.1
|
Certification
of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As
Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002
|
Exhibit
32.2
|
Certification
of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As
Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002
|
(1)
Filed as an exhibit to the Company’s Current Report on Form 8-K for the
event dated January 28,
2008
and incorporated by reference herein.
|
(2)
Filed as an exhibit to the Company’s Annual Report on Form 10-K for the
period ended December 31, 2007 and incorporated by reference
herein.
|
*
Denotes management compensation plan or
arrangement.
|
|
|
|
Iconix
Brand Group, Inc.
(Registrant)
|
|
|
|
|
|
|
|
|
Date:
May 7, 2008
|
|
|
/s/
Neil
Cole
|
|
|
|
Neil
Cole
Chairman
of the Board, President
and
Chief Executive Officer
(on
Behalf of the Registrant)
|
Date:
May 7, 2008
|
|
|
/s/
Warren Clamen
|
|
|
|
Warren
Clamen
Chief
Financial Officer
|